<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01584999</url>
  </required_header>
  <id_info>
    <org_study_id>Prot 210163</org_study_id>
    <nct_id>NCT01584999</nct_id>
  </id_info>
  <brief_title>Effects on Septic Patient's Microcirculation of the Transfusion of Different Types of Concentrated RBCs.</brief_title>
  <official_title>Effects on the Septic Patient's Microcirculation of the Transfusion of Three Different Types of Concentrated Red Blood Cells.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Politecnica delle Marche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliero, Universitaria Ospedali Riuniti</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Università Politecnica delle Marche</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to evaluate the effects, on microcirculation of septic patient, of three
      types of RBCs: 1- fresh standard RBCs (storage &lt;10 days); 2-leukodepleted RBCs and 3-old
      standard RBCs (storage &gt;15 days) respectively. Before and 1 hour after the transfusion,
      microcirculation is evaluated using Sidestream Dark Field Imaging (SDF) and Near InfraRed
      Spectroscopy (NIRS) with vascular occlusion test. We also monitor temperature, heart rate,
      mean blood pressure, hemochrome, blood gases, blood lactates and SOFA score.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microcirculatory Flow Index (MFI) before and after blood transfusion.</measure>
    <time_frame>One hour after the end of blood transfusion compared with before blood transfusion</time_frame>
    <description>Microcirculatory Flow Index detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quality of blood flow at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve MFI.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfused Vessel Density (PVD)</measure>
    <time_frame>One hour after the end of blood transfusion compared with before blood transfusion</time_frame>
    <description>Perfused Vessel Density detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quantity of well perfused vessels at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve PVD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>StO2 upslope</measure>
    <time_frame>One hour after the end of blood transfusion compared with before blood transfusion</time_frame>
    <description>StO2 upslope is measured with Near InfraRed Spectroscopy at the tenar muscle. It represents the velocity of the recovery of the tissue oxygen saturation after a short period of ischemia of the hand, the Vascular Occlusion Test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Blood Lactate</measure>
    <time_frame>One hour after the end of blood transfusion compared with before blood transfusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial pH</measure>
    <time_frame>One hour after the end of blood transfusion compared with before blood transfusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>One hour after the end of blood transfusion compared with before blood transfusion</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Septic Patients</condition>
  <arm_group>
    <arm_group_label>Fresh not-leukocyte-reduced RBCs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresh RBCs leukocyte-reduced</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>RBCs with storage longer than 15 days</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood transfusion</intervention_name>
    <description>RBCs have been transfused in septic patient admitted in ICU</description>
    <arm_group_label>Fresh not-leukocyte-reduced RBCs</arm_group_label>
    <arm_group_label>Fresh RBCs leukocyte-reduced</arm_group_label>
    <arm_group_label>RBCs with storage longer than 15 days</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with sepsis, severe sepsis or septic shock who, according to clinical
             evaluation, need a hemotransfusion.

        Exclusion Criteria:

          -  Patients under 18 years of age; Pregnancy; Coagulative disorders; Cardiogenic shock
             (Met&lt;4;)Acute massive bleeding (&gt;8 U)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abele Donati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Politecnica delle Marche</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University ICU, AOU Ospedali Riuniti</name>
      <address>
        <city>Torrette di Ancona</city>
        <state>Ancona</state>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2012</study_first_submitted>
  <study_first_submitted_qc>April 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2012</study_first_posted>
  <last_update_submitted>May 21, 2012</last_update_submitted>
  <last_update_submitted_qc>May 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università Politecnica delle Marche</investigator_affiliation>
    <investigator_full_name>Abele Donati, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

